Prenetics Global Limited (NASDAQ: PRE) acquired a majority stake in ACT Genomics Holdings Company Limited (“ACT”), an Asia-based genomics company specialising in precision oncology with operations...
This content is for Standard 1 Year members only. LoginJoin Now